BMEC barrier selectivity arises from several coordinated features rather than a single mechanism. Closely connected cell junctions restrict movement between neighboring cells, while selective transport systems regulate which substances cross through the cells. Low vesicular permeability further limits nonspecific transfer. Together, these properties help control exposure of neural tissue to circulating nutrients, drugs, pathogens, and inflammatory signals.
Interactions with pericytes and astrocytes add a supporting-cell dimension to BMEC-based systems. Rather than examining endothelial behavior in isolation, researchers can use these relationships to represent the vascular interface in a more biologically contextual way. This is relevant when studying neural homeostasis or asking how vascular changes may contribute to neurological disease.
Selective transport systems permit regulated passage rather than unrestricted exchange. In BMEC research, examining these systems helps distinguish substances that can move between blood and neural tissue from those that are more effectively restricted. That distinction supports studies of nutrient availability, drug access, pathogen movement, and inflammatory signaling at the brain vascular interface.
BMEC-based models can investigate how specific classes of substances behave at the blood-brain barrier. Researchers may examine the movement of nutrients, drugs, pathogens, or inflammatory signals between blood and neural tissue. The resulting information helps connect barrier transport properties with neural exposure and with vascular contributions to neurological disease.
Primary BMECs and stem-cell-derived BMEC models provide two sources for representing the brain vascular interface. The overview supports their use in barrier modeling, drug screening, and brain-delivery research, without identifying one as universally superior. Selecting between them therefore depends on the research question and the type of model needed for the study.
These cells are especially useful when a study needs to connect vascular barrier behavior with a neuroscience outcome. Applications include investigating vascular contributions to neurological disease, evaluating how drugs or nutrients reach neural tissue, and developing targeted brain-delivery strategies. They also support screening efforts focused on compounds or transport approaches compatible with the barrier.